First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of panitumumab to standard
chemotherapy in first-line treatment of advanced Non Small Cell Lung Cancer improves the
treatment outcome. Patients are selected based on triple mutational status.